Cellular reprogramming is the hottest topic in longevity science, with tech titans like Sam Altman investing in it. It's now ...

Biotech startup NewLimit secures a major funding round after claiming a ‘breakthrough discovery’ of a prototype medicine that ...

The experimental treatment, known as ER-100, is being tested in patients suffering from glaucoma and other forms of ...

Life Biosciences says it just dosed its first patient in an FDA-approved clinical trial to reverse age-related blindness.

As AI transforms biology, longevity startups are attracting investors, advancing toward clinical milestones, and reshaping ...

(Siarhei_Fetisenkov/Creatas Video+/Getty Images Plus) An eagerly awaited and controversial clinical trial to 'wind back the ...

Aging is a complex process that has long puzzled scientists. A recent study published in Engineering proposes a new theory called pro-aging metabolic reprogramming (PAMRP), which could change our ...

NewLimit’s lead liver combo has proven its worth in preclinical models, Kimmel told Fierce, with the ability to boost ...

Scientists have launched a human trial testing gene therapy that could make aging cells behave like younger ones.

Aging is a complex process that has long puzzled scientists. A recent study published in Engineering proposes a new theory called Pro-Aging Metabolic Reprogramming (PAMRP), which could change our ...